McDermott International Inc. (MDR) Drops 5.74% on December 28

Equities Staff |

McDermott International Inc. (MDR) was one of the Russell 2000's biggest losers for Monday December 28 as the stock slid 5.74% to $3.37, a loss of $-0.205 per share. Starting at an opening price of $3.51 a share, the stock traded between $3.36 and $3.51 over the course of the trading day. Volume was 983,774 shares over 4,777 trades, against an average daily volume of 3.84 million shares and a total float of 238.97 million.

The losses send McDermott International Inc. down to a market cap of $804.14 million. In the last year, McDermott International Inc. has traded between $6.00 and $2.10, and its 50-day SMA is currently $4.61 and 200-day SMA is $4.73.

The stock has a P/E Ratio of 51.

McDermott International Inc is an engineering, procurement, construction and installation company engaged in designing and executing complex offshore oil and gas projects.

McDermott International Inc. is based out of Houston, TX and has some 13,800 employees. Its CEO is David Dickson.

For a complete fundamental analysis analysis of McDermott International Inc., check out’s Stock Valuation Analysis report for MDR. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…